Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth Woods

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Nature|October 21, 2025
The TrumpRx website won't slash drug prices - but this willBeth Woods
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 14, 2011
Prioritizing pharmacogenetic research: a value of information analysis of CYP2D6 testing to guide breast cancer treatmentBeth Woods, David Veenstra, Neil Hawkins
Pharmacoeconomics|December 31, 2015
Assessing the Value of New Treatments for Hepatitis C: Are International Decision Makers Getting this Right?Beth Woods, Rita Faria, Susan Griffin
Pharmacoeconomics|July 4, 2025
Correction: A Framework for Using Cost‑effectiveness Analysis to Support Pricing and Reimbursement Decisions for New Pharmaceuticals in a Context of Evolving Treatments, Prices, and EvidenceBeth Woods, Alfredo Palacios, Mark Sculpher
Pharmacoeconomics|December 31, 2024
A Framework for Using Cost-effectiveness Analysis to Support Pricing and Reimbursement Decisions for New Pharmaceuticals in a Context of Evolving Treatments, Prices, and EvidenceBeth Woods, Alfredo Palacios, Mark Sculpher
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 28, 2009
How far do you go? Efficient searching for indirect evidenceNeil Hawkins, David A Scott, Beth Woods
Research Synthesis Methods|November 28, 2015
'Arm-based' parameterization for network meta-analysisNeil Hawkins, David A Scott, Beth Woods
BMJ (Clinical Research Ed.)|November 11, 2025
Equitable access to costly new drugsBeth Woods, Renske Ten Ham, Karl Claxton
Health Economics|August 3, 2021
Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to patients served by health systemsBeth Woods, Aimée Fox, Mark Sculpher, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 19, 2016
Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further ResearchBeth Woods, Paul Revill, Mark Sculpher, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Nature|October 21, 2025
The TrumpRx website won't slash drug prices - but this willBeth Woods
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 14, 2011
Prioritizing pharmacogenetic research: a value of information analysis of CYP2D6 testing to guide breast cancer treatmentBeth Woods, David Veenstra, Neil Hawkins
Pharmacoeconomics|December 31, 2015
Assessing the Value of New Treatments for Hepatitis C: Are International Decision Makers Getting this Right?Beth Woods, Rita Faria, Susan Griffin
Pharmacoeconomics|July 4, 2025
Correction: A Framework for Using Cost‑effectiveness Analysis to Support Pricing and Reimbursement Decisions for New Pharmaceuticals in a Context of Evolving Treatments, Prices, and EvidenceBeth Woods, Alfredo Palacios, Mark Sculpher
Pharmacoeconomics|December 31, 2024
A Framework for Using Cost-effectiveness Analysis to Support Pricing and Reimbursement Decisions for New Pharmaceuticals in a Context of Evolving Treatments, Prices, and EvidenceBeth Woods, Alfredo Palacios, Mark Sculpher
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 28, 2009
How far do you go? Efficient searching for indirect evidenceNeil Hawkins, David A Scott, Beth Woods
Research Synthesis Methods|November 28, 2015
'Arm-based' parameterization for network meta-analysisNeil Hawkins, David A Scott, Beth Woods
BMJ (Clinical Research Ed.)|November 11, 2025
Equitable access to costly new drugsBeth Woods, Renske Ten Ham, Karl Claxton
Health Economics|August 3, 2021
Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to patients served by health systemsBeth Woods, Aimée Fox, Mark Sculpher, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 19, 2016
Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further ResearchBeth Woods, Paul Revill, Mark Sculpher, et al.
Pageof 5